COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway

Med Hypotheses. 2020 Dec:145:110331. doi: 10.1016/j.mehy.2020.110331. Epub 2020 Oct 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Rheumatoid*
  • COVID-19*
  • Cholinesterase Inhibitors
  • Galantamine
  • Humans
  • Neuroimmunomodulation
  • Pandemics
  • Respiratory Distress Syndrome*
  • SARS-CoV-2
  • Vagus Nerve Stimulation*

Substances

  • Cholinesterase Inhibitors
  • Galantamine